The Converge IDE Trial

Apr 1

Hybrid Ablation is gaining steam! The Converge IDE trial proves the advantage of the Hybrid Approach to stand-alone catheter ablation in difficult to treat persistent and long-standing persistent atrial fibrillation patients.

Atrial FibrillationElectrophysiologyStrokeStopAFib.orgChristian ShultsMedstarConverge IDE TrialConvergent Hybrid ProcedureLeft atrial appendage

Armin Kiankhooy

The Converge IDE Trial

Alcohol and Atrial Fibrillation

The Patient Experience with Atrial Fibrillation & StopAFib.org